Ellen Goldberg's most recent trade in Castle Biosciences Inc was a trade of 13,667 Restricted Stock Units done . Disclosure was reported to the exchange on May 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Castle Biosciences Inc | Ellen Goldberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 13,667 | 13,667 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Ellen Goldberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 8,673 | 27,254 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | Ellen Goldberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 8,673 | 0 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Ellen Goldberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2024 | 440 | 18,581 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | Ellen Goldberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2024 | 440 | 0 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Ellen Goldberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2024 | 8,636 | 0 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Ellen Goldberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2024 | 8,636 | 18,141 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | Ellen Goldberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 8,673 | 8,673 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Ellen Goldberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2023 | 440 | 9,505 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | Ellen Goldberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2023 | 440 | 440 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Ellen Goldberg | Director | Purchase of securities on an exchange or from another person at price $ 17.27 per share. | 05 Jun 2023 | 2,500 | 9,065 (0%) | 0% | 17.3 | 43,175 | Common Stock |
| Castle Biosciences Inc | Ellen Goldberg | Director | Purchase of securities on an exchange or from another person at price $ 11.23 per share. | 05 Jun 2023 | 2,300 | 6,565 (0%) | 0% | 11.2 | 25,829 | Common Stock |
| Castle Biosciences Inc | Ellen Goldberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2023 | 3,825 | 0 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Ellen Goldberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2023 | 3,825 | 4,265 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | Ellen Goldberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 8,636 | 8,636 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Ellen Goldberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2022 | 440 | 880 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Ellen Goldberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2022 | 440 | 440 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | Ellen Goldberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 7,647 | 7,647 | - | - | Stock option (right to buy) | |
| Castle Biosciences Inc | Ellen Goldberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 3,825 | 3,825 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Ellen Goldberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2021 | 5,365 | 5,365 | - | - | Stock option (right to buy) | |
| Castle Biosciences Inc | Ellen Goldberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2021 | 1,320 | 1,320 | - | - | Restricted Stock Units |